Amyloidosis trials in Switzerland

In Switzerland 8 Also abroad 184

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)
Where
Basel, Bern, Geneva, Lausanne, Lucerne, Sankt Gallen, Zurich
Age
18 years and over
People
300
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT04776824
Phase 3Taking people
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Basel, Bern, Geneva, Lucerne, Sankt Gallen
Age
18 years to 85 years
People
1,750 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00
Phase 3Taking people
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Where
Bern
Age
18 years to 85 years
People
125 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00
No phaseTaking people
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Where
Multiple Locations
Age
18 years and over
People
2,000 worldwide
Run by
Bayer
See details and how to joinNCT07235462
Phase 3Not yet taking people in Switzerland
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
Where
Basel, Bern, Lucerne, Sankt Gallen, Zurich
People
1,180 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00
No phaseNot yet taking people in Switzerland
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
Where
Zurich
Age
18 years and over
People
50
Run by
University of Zurich
See details and how to joinNCT07624760
No phaseTaking people
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
Where
Muttenz
Age
18 years to 99 years
People
400 worldwide
Run by
Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06205953
No phaseTaking people
Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
Where
Zurich
People
50
Run by
Dominik Benz
See details and how to joinNCT07112066